Top Health Tech Companies in London (376)
Cencora is a leading pharmaceutical solutions organization centered on improving the lives of people and animals everywhere. With 46,000+ global team members, we have the opportunity to make a positive impact on healthcare in communities everywhere. Our team members are empowered to activate their careers through a collective of tools and resources designed to support individual career interests and...
Cencora's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue has risen across multiple periods, including fiscal 2025 up about 9% to roughly $321 billion and mid‑single‑digit year‑over‑year increases in fiscal 2026 quarters. Disclosures also note Q4 FY2025 revenue of $83.7 billion, up 5.9% year over year.
Profitability: Adjusted operating income and EPS expanded, with FY2025 adjusted EPS up 16% to $16.00 and Q2 FY2026 GAAP EPS rising to $8.40 alongside a raised full‑year adjusted EPS outlook to about $17.70–$17.90. Management also indicated double‑digit adjusted operating income growth expected for FY2026.
Resilient & Sustainable Growth: Momentum spans FY2023–FY2026 to date, with revenue progressing from about $262 billion (FY2023) to $294 billion (FY2024) to $321 billion (FY2025) and continued gains in 2026. Portfolio refocusing and acquisitions in specialty care (e.g., Retina Consultants of America, OneOncology) are described as engines supporting ongoing expansion and margin mix.
.png)
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products.
GRAIL's Top Stability & Growth Strengths
Strong Revenue Growth: Galleri and total revenue have risen consistently, with full-year 2025 up 17% and U.S. Galleri up 26%, followed by Q1–Q2 2026 total revenue gains of 28% and 26% alongside 50% and 35% volume growth. This cadence, including Q4 2025 Galleri revenue up 31%, indicates sustained commercial momentum after the June 2024 spin‑off.
Strategic Partnerships: Channel and platform integrations such as Epic EHR and Quest Diagnostics, plus collaborations like Samsung for Asian commercialization, are expanding access and streamlining ordering. Additional distribution wins (e.g., Priority Health employer plans and digital health channels) reinforce multi‑channel penetration for Galleri.
Investor Backing & Capital Strength: The company reports a substantial cash balance (~$861.6M as of Q2 2026) and closed a $110M equity financing with Samsung, bolstering financial flexibility. Public listing post‑spin‑off further enhances capital‑markets access to fund trials and commercialization.
For more than two decades, Imprivata has been redefining how life- and mission-critical industries secure and manage digital identities. We empower healthcare and enterprise organizations to enable fast, compliant, and secure access to technology—allowing clinicians and staff to stay focused on what matters most: patient care and operational excellence. Our digital identity platform is purpose-built for complex environments where every second...
Imprivata's Top Stability & Growth Strengths
Strong Revenue Growth: Top line is described as expanding steadily in recent years, with continued growth expected. Separate reporting cites roughly $500 million in annual revenue and rapid momentum, even as exact figures vary.
Healthy Cash Flow: Cash generation has improved enough for a late‑2025 credit rating upgrade, with projections to produce over $100 million in free cash flow within the next 12–24 months. Leverage is expected to trend down alongside strong margins.
Customer Loyalty & Retention: Retention is characterized as consistently high with net expansion of spend, signaling durable relationships and effective cross‑sell within the installed base. A sizable customer count (over 4,000 organizations) supports stickiness across regions.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.
Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.
Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.
Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.
Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.
Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. Cancer is smart. Together, we can be smarter. Flatiron Health is an independent affiliate of the Roche Group.
Flatiron Health's Top Stability & Growth Strengths
Market Expansion: International partnerships across the UK, Germany, and Japan—culminating in a first Scottish agreement in 2026—are described as tripling the network in 2025 and adding nearly 70% ex‑U.S. growth in 2026. These moves indicate a materially broader geographic footprint for evidence generation.
Strategic Partnerships: Collaborations with organizations such as NHS Greater Glasgow and Clyde, Quest Diagnostics, Abbott, TailorMed, and Unicancer reflect deepening integration at the point of care and with research stakeholders. These relationships suggest expanding routes to market and data acquisition.
Product Line Growth: New offerings like Flatiron Telescope, AI‑powered oncology datasets, and an AI data‑quality/validation framework signal active investment in products and capabilities. Conference acceptances at ISPOR/ASCO/WCLC in 2026 further underscore ongoing commercialization and scientific engagement.
Envisionit Deep AI™ is an innovative medical technology company using Artificial Intelligence to transform medical imaging diagnosis. Trained and validated by radiologists for medical practitioners, our products detect and highlight abnormalities across diagnostic medical images
Digistain ® - Leading digital transformation in cancer diagnostics - radically faster gold standard risk scoring analytics at a dramatically lower cost A Digital Solution To Cancer Grading And Prognosis approved by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA), DIGISTAIN® is a patented risk profiling test for hormone receptor-positive breast cancer patients. Digistain’s easy-to-read report provides both physician...
HTN Best Solution for Connecting Healthcare Award 2023 | Digitally empowering independent community pharmacies to deliver more private services, reducing their reliance on NHS revenues, and making them more accessible so that your local community will have better access to healthcare services in the UK.
Frame was put on Earth to make sure keeping fit and healthy never feels like a chore. A place to MOVE, SWEAT and FUEL your Frame daily. We are known for our feel-good, energetic and fun-filled classes. You can sweat it out with a high-intensity fitness class; dance, shake and party like it's 1999; or get zen with a restorative...
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
SERG Technologies is a digital health and care solutions provider for people living with neurodegenerative movement disorders.
Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home. Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London...
eConsult Health is a collection of digital triage solutions for Primary, Emergency Care and outpatients eConsult enables NHS based GP practices to offer online consultations to their patients. This allows patients to submit their symptoms or requests to their own GP electronically and offers around the clock NHS self-help information, signposting to services and a symptom checker. eConsult is the most widely...
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our...
Medical Imaging Partnership has been delivering high-quality radiology services for both the NHS and private sector for over a decade. We have multiple sites and centres across the south coast of the UK, all led by qualified and experienced healthcare professionals. Our services include 3TMRI, MRI, CT, ultrasound, x-ray, DEXA scans and ultrasound guided steroid injections.
Wellhub is a corporate wellness platform that connects employees to the best partners for fitness, mindfulness, therapy, nutrition, and sleep, all included in one subscription designed to cost less than each individual partner. More than 26,000 companies in 13 countries use Wellhub to give their millions of employees access to best-in-class corporate wellbeing programs that are proven to drive widespread employee...
Wellhub's Top Stability & Growth Strengths
Strong Market Position & Advantage: Wellhub is repeatedly characterized as operating the world’s largest corporate wellness network, with leadership in the U.S., a broad employer roster including large enterprises, and a multi‑modal partner ecosystem. Scale across tens of thousands of corporate clients, millions of subscribers, and a vast partner network reinforces competitive advantage versus direct aggregators.
Market Expansion: Company updates and industry coverage describe rapid growth in subscribers and check-ins, substantial partner additions, and acquisitions (e.g., Fitprime and Urban Sports Club) that extend its geographic footprint. The platform highlights becoming the largest U.S. network and connecting nearly 40,000 corporate clients and over 5 million employee subscribers.
Investor Backing & Capital Strength: An $85 million Series F at a multi‑billion valuation and continued references to strong investor confidence support ongoing expansion and product innovation. Funding has been linked to U.S. growth, enhanced product experience, and entry into new wellness categories.
Born on South Molton Street, London in 1971, Molton Brown is an icon of uniquely British style. Our Eaux de Parfum and Toilette, and Bath, Body, Hair and Home collections have been Made in England since day one – and we’re committed to this for our future. Sourcing only the best ingredients in exceptional fragrance concentrations, our quality has awarded...
Understand your health through clinical assessments. Data-driven, doctor-built, dedicated to clinical excellence. Targeting everything from anxiety to migraines, forgetfulness to brain fog, concussion to depression, Mindstep is your ultimate, jam-packed brain and mental health app designed by doctors & clinically validated from start to finish.
Everyday health insurance with a difference - simple, practical and affordable. We help businesses take care of their people, the self-employed take care of themselves, and employees take care of their health - and their families. From £7 per person per month, options include: 24/7 GP access Physio appointments Health checks Diagnosis Treatment Stress support Dental/Optical Find out more at...
